References
Fischer K, Othman AS, Fink AM, Tandon M, Dixon M, Robrecht S, et al.
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting
Conditions. N Engl J Med 2019; 380:2225-2236.
Broyde A, Boycov O, Strenov Y, Okon E, Shpilberg O, Bairey O. Role and
prognostic significance of the Ki-67 index in non-Hodgkin’s lymphoma.
Am J Hematol. 2009; 84(6):338-43.